Abstract:The selective inhibition of expression of specific genes by oligonucleotides via an antisense or antigene strategy provides an attractive and elegant approach to drug discovery. Several requirements must be fulfilled by a potential antisense oligonucleotide including the improvements in their stability to nuclease digestion, in their ability to penetrate the cell membrane and in their efficient hybridization to the target RNA/DNA. Isonucleosides represent a novel class of carbohydrate modified nucleosides in which the nucleobase is linked to various positions of ribose other than C1'. The torsion angles in the sugar phosphate backbones of such oligonucleotides consisting of isonucleosides exhibit profound changes compared to regular oligonucleotides. These alternations in torsion angles might affect the recognition of such oligomers by nuclease. It could also be anticipated that the bases in the modified oligonucleotides retain their hybridization properties with complementary sequences. In the first part of this paper, we discussed the hybridization properties and enzymatic stability of oligonucleotides bearing such isonucleosides. It is reported that several types of peptides, such as nuclear transport signal sequence, viral fusion peptides, hydrophobic peptides, and signal peptides, have shown intrinsic ability to perturb cell membrane. It would be interesting to investigate whether such kinds of peptide conjugate could be used for the purpose of improving their cell membrane permeability. In the second and third part of this paper, we reported the synthesis and biological properties of antisense oligonucleotide conjugates. Finally, we described the formation of parallel intermolecular G quadruplex structure by isonucleoside.

Synthesis in solution of oligodeoxynucleotides and some their 5'- and 3'-linked derivatives.

Oligonucleotide synthesis under mild deprotection conditions

Therapeutic Oligonucleotides: State of the Art

A Versatile Solid-Phase Approach to the Synthesis of Oligonucleotide Conjugates with Biodegradable Hydrazone Linker

A Catalytic Approach for the Synthesis of Peptide–Oligonucleotides Conjugates in Aqueous Solution or On‐Column

A Unified Phosphoramidite Platform for the Synthesis of Morpholino Oligonucleotides and Diverse Chimeric Backbones

Oligonucleotides: Current Trends and Innovative Applications in the Synthesis, Characterization, and Purification

Synthesis, Biophysical and Biological Evaluation of Splice-Switching Oligonucleotides with Multiple LNA-Phosphothiotriester Backbones

Chemistry, structure and function of approved oligonucleotide therapeutics

Synthesis and Enzymatic Stability of Oligonucleotides Consisting of Isonucleosides

Controlled enzymatic synthesis of oligonucleotides

Synthesis and Duplex Stabilization of Oligonucleotides Consisting of Isonucleosides

A General and Efficient Approach for the Construction of RNA Oligonucleotides Containing a 5′-Phosphorothiolate Linkage

Solution phase synthesis of short oligoribonucleotides on a precipitative tetrapodal support

Catalytic asymmetric and stereodivergent oligonucleotide synthesis

The Chemistry and Biology of Oligonucleotide Conjugates

Studies on drug targeting to nucleic acids

Tuning the Solubility of Soluble Support Constructs in Liquid Phase Oligonucleotide Synthesis

Template-dependent DNA ligation for the synthesis of modified oligonucleotides

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Synthesis and Hybridization Properties of an Oligonucleotide Consisting of 1′,4′-Anhydro-2′,5′-dideoxy-2′-(thymin-1-yl)-d-altritol